Wednesday, May 15, 2024

Jubilant Life Sciences receives ANDA approval for Celecoxib Capsules

Thursday, April 6, 2017, 6:08
This news item was posted in Business category and has 0 Comments so far.
Jubilant Life Sciences receives ANDA approval for Celecoxib Capsules

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, the generic version of Celebrex of GD Searle, which is used for the treatment of Osteoarthritis and Rheumatoid Arthritis.

You can leave a response, or trackback from your own site.

Leave a Reply